{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:33:14Z","timestamp":1736919194048,"version":"3.33.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.2515\/therapie:2005032","type":"journal-article","created":{"date-parts":[[2007,3,12]],"date-time":"2007-03-12T11:32:00Z","timestamp":1173699120000},"page":"249-255","source":"Crossref","is-referenced-by-count":2,"title":["Les vaccins conjugu\u00e9s"],"prefix":"10.1016","volume":"60","author":[{"given":"Bernard","family":"Fritzell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2515\/therapie:2005032_bb1080","first-page":"164","article-title":"Infections invasives \u00e0 H. influenzae, L. monocytogenes, N. meningitidis, S. pneumoniae, S. agalactiae et S. pyogenes en France en 2001-2002","volume":"34","author":"Georges","year":"2004","journal-title":"Bulletin Epid\u00e9miologique Hebdomadaire"},{"key":"10.2515\/therapie:2005032_bb1085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00013542-199601000-00001","article-title":"Responsiveness of infants to capsular polysaccharides: impact on vaccine development","volume":"7","author":"Rijkers","year":"1996","journal-title":"Rev Med Microbiol"},{"key":"10.2515\/therapie:2005032_bb1090","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0091-6749(96)80078-9","article-title":"Human immune response to pneumococcal polysaccharides: complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells","volume":"97","author":"Peset Llopis","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.2515\/therapie:2005032_bb1095","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1084\/jem.50.4.533","article-title":"Chemoimmunological studies on conjugated carbohydrate proteins. II. Immunological specificity of synthetic sugar-protein antigen","volume":"50","author":"Avery","year":"1929","journal-title":"J Exp Med"},{"key":"10.2515\/therapie:2005032_bb1100","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1084\/jem.152.2.361","article-title":"Preparation, characterization and immunogenicity of Haemophilus influenzae type b polysaccharide: protein conjugates","volume":"152","author":"Schneerson","year":"1980","journal-title":"J Exp Med"},{"key":"10.2515\/therapie:2005032_bb1105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00006454-199102000-00004","article-title":"Efficacy in infancy of oligosaccharide conjugate H. influenzae type b (HbOC) vaccine in a United States population of 61,080 children: The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group","volume":"10","author":"Black","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"10.2515\/therapie:2005032_bb1110","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJM199106203242503","article-title":"The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex","volume":"324","author":"Santosham","year":"1991","journal-title":"N Engl J Med"},{"key":"10.2515\/therapie:2005032_bb1115","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(96)09267-7","article-title":"Randomised trial of Haemophilus influenzae type b tetanus protein conjugate vaccine for prevention of pneumonia and meningitis in Gambian infants","volume":"349","author":"Mulholland","year":"1997","journal-title":"Lancet"},{"key":"10.2515\/therapie:2005032_bb1120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archpedi.1994.02170010053011","article-title":"Eradication of H. influenzae type b disease in Southern California","volume":"148","author":"Vadheim","year":"1994","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.2515\/therapie:2005032_bb1125","first-page":"1041","article-title":"Recent trends in pediatric Haemophilus influenzae type b infections in Canada. Immunization Monitoring Program, Active (IMPACT) of the Canadian Paediatric Society and the Laboratory Centre for Disease Control","volume":"154","author":"Scheifele","year":"1996","journal-title":"CMAJ"},{"key":"10.2515\/therapie:2005032_bb1130","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0140-6736(94)92387-6","article-title":"Efficacy of Hib vaccine","volume":"344","author":"Teare","year":"1994","journal-title":"Lancet"},{"key":"10.2515\/therapie:2005032_bb1135","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/0140-6736(92)92117-X","article-title":"Rapid disappearance of H. influenzae type b meningitis after routine childhood immunization with conjugate vaccines","volume":"340","author":"Peltola","year":"1992","journal-title":"Lancet"},{"first-page":"50","year":"1998","series-title":"Bull Epidemiol Hebd","key":"10.2515\/therapie:2005032_bb1140"},{"key":"10.2515\/therapie:2005032_bb1145","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/infdis\/164.5.982","article-title":"Reduction of oropharyngeal carriage of H. influenzae type b (Hib) in children immunized with an Hib conjugate vaccine","volume":"164","author":"Takala","year":"1991","journal-title":"J Infect Dis"},{"key":"10.2515\/therapie:2005032_bb1150","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3476(05)83529-2","article-title":"Decreased Haemophilus colonization in children vaccinated with H. influenzae type b conjugate vaccine","volume":"122","author":"Murphy","year":"1993","journal-title":"J Pediatr"},{"key":"10.2515\/therapie:2005032_bb1155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.53393\/rial.1978.38.37124","article-title":"Avalia\u00e7\u00e3o do efeito protetor da vacina polissar\u00eddica antimeningoc\u00f3cica do grupo C, em crian\u00e7as de 6 a 36 meses","volume":"38","author":"Taunay","year":"1978","journal-title":"Rev Inst Adolfo Lutz"},{"key":"10.2515\/therapie:2005032_bb1160","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.285.2.177","article-title":"Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec","volume":"285","author":"De Wals","year":"2001","journal-title":"JAMA"},{"key":"10.2515\/therapie:2005032_bb1165","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/314753","article-title":"Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory","volume":"179","author":"Richmond","year":"1999","journal-title":"J Infect Dis"},{"key":"10.2515\/therapie:2005032_bb1170","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0264-410X(00)00241-3","article-title":"A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants","volume":"19","author":"English","year":"2000","journal-title":"Vaccine"},{"key":"10.2515\/therapie:2005032_bb1175","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"key":"10.2515\/therapie:2005032_bb1180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(00)03594-7","article-title":"Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England","volume":"357","author":"Ramsay","year":"2001","journal-title":"Lancet"},{"key":"10.2515\/therapie:2005032_bb1185","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci 1year after meningococcal C conjugate polysaccharide vaccination: The UK Meningococcal Carriage Group","volume":"359","author":"Maiden","year":"2002","journal-title":"Lancet"},{"key":"10.2515\/therapie:2005032_bb1190","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"key":"10.2515\/therapie:2005032_bb1195","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children: Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.2515\/therapie:2005032_bb1200","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.inf.0000129685.04847.94","article-title":"Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in northern California Kaiser Permanente","volume":"23","author":"Black","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.2515\/therapie:2005032_bb1205","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/315009","article-title":"Immunogenicity and impact on nasopharyngeal carriage of nonavalent pneumococcal conjugate vaccine","volume":"180","author":"Mbelle","year":"1999","journal-title":"J Infect Dis"},{"key":"10.2515\/therapie:2005032_bb1210","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/01.inf.0000069761.11093.c3","article-title":"Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers","volume":"22","author":"Dagan","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.2515\/therapie:2005032_bb1215","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/01.inf.0000069760.65826.f2","article-title":"Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings","volume":"22","author":"Givon-Lavi","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.2515\/therapie:2005032_bb1220","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of pneumococcal conjugate vaccine against acute otitis medi","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"10.2515\/therapie:2005032_bb1225","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059571630292X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059571630292X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T22:43:56Z","timestamp":1736894636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004059571630292X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S004059571630292X"],"URL":"https:\/\/doi.org\/10.2515\/therapie:2005032","relation":{},"ISSN":["0040-5957"],"issn-type":[{"type":"print","value":"0040-5957"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}